Literature DB >> 33877137

Levetiracetam-induced systemic lupus erythematosus.

Praveen Jadhav1, Teja Kulkarni2, Janhavee Jadhav3, Saourabh Desai4, Rahul Baviskar5.   

Abstract

Systemic lupus erythematosus (SLE) is a rare autoimmune disorder in a physician's practice, commonly presenting in young females. It is rare for SLE to present at a late age. Though SLE is idiopathic, sometimes it can present as an adverse reaction to drugs. Quite a few drugs are implicated in this process. However, there are no reports of levetiracetam causing SLE. Here, we present a case of 62-year-old female presenting with SLE after consumption of levetiracetam for 1 year for her epilepsy. Erythematosus rash was her main symptom. This was associated with a strong positivity of antinuclear antibody. The symptoms remitted completely after the discontinuation of levetiracetam, suggesting them to be because of drug-induced lupus (DIL). DIL differs from SLE in being mild, affecting atypical age groups and resolving completely on withdrawal of the drug.

Entities:  

Keywords:  adverse drug reaction; antiepileptic; drug-induced lupus; levetiracetam; systemic lupus erythematosus

Year:  2021        PMID: 33877137     DOI: 10.4997/JRCPE.2021.114

Source DB:  PubMed          Journal:  J R Coll Physicians Edinb        ISSN: 1478-2715


  1 in total

Review 1.  Thrombosis and Anticoagulation Therapy in Systemic Lupus Erythematosus.

Authors:  Wenjun Yuan; Fengjun Guan
Journal:  Autoimmune Dis       Date:  2022-06-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.